Karuna Therapeutics
Why Robinhood?
You can watch KRTX and buy or sell other stocks, ETFs, and their options commission-free!About KRTX
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.
KRTX Key Statistics
Stock Snapshot
As of today, Karuna Therapeutics(KRTX) shares are valued at $329.83. The company's market cap stands at 12.6B, with a P/E ratio of -28.13.
During the trading day, Karuna Therapeutics(KRTX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Karuna Therapeutics(KRTX) stock has reached 0, versus its average volume of 525.45K.
The stock's 52-week range extends from a low of $158.38 to a high of $329.99.
The stock's 52-week range extends from a low of $158.38 to a high of $329.99.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.